The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

The cells were collected at 24 h after illumination for further assays. To measure the insulin in the cell culture medium, cells were centrifuged for 10 min at 10,000 g. And the insulin concentration ...

After ten weeks, insulin sensitivity ... whose beta cells were already mature before the fasting began, remained unaffected. The team compared their mouse findings to data from human tissues.

Likewise, Dalbay and collaborators demonstrated that differentiation of human mesenchymal stem cells into adipocytes required primary cilium elongation associated with recruitment of IGF-1βR onto the ...

Junevity, a biotechnology company on a mission to extend lifespan and healthspan by resetting cell damage from age-related ...

Insulin-like growth factor (IGF ... from the results of animal and cell-culture studies, most growth-promoting effects of GH are believed to be mediated by IGF1. Consistent with this hypothesis ...

Merilog is a rapid-acting human insulin ... 4 million rely on insulin therapy to effectively manage their blood glucose levels. Insulin enables glucose to enter the body’s cells, providing ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Insulin allows cells to absorb and use glucose. In people with insulin resistance, the cells are unable to use insulin effectively. Insulin resistance occurs when cells in the body do not respond ...